Inimmune
  • About
    • Vision/Mission
    • About Us
    • Management Team
    • Board of Directors
  • Pipeline
  • Research
  • News
  • Investors
  • Careers
  • Contact
Select Page

Science Behind the Silent Killer

Jun 7, 2020 | News

The science behind the silent killer.  Here is how Inimmune is developing vaccines to help solve the opioid epidemic.

Read full article:

Science and the Silent Killer

Recent Posts

  • For Missoula’s Inimmune, a $22 M Series A Round with Two Bear Capital is the latest record set – MT High Tech Business Alliance
  • Nation angler Evans helping with vital COVID research
  • UM Receives Largest Single Research Award in its History
  • Inimmune raises $22 Million in Series A Funding Led by Two Bear Capital
  • Biotech Company Announces $22 Million Investment Led by Mike Goguen’s Firm

Archives

  • February 2021
  • October 2020
  • July 2020
  • June 2020
  • October 2019
  • December 2018
  • February 2018
  • July 2017
  • November 2016
  • August 2016

BACK TO NEWS

© 2020 Inimmune